211 related articles for article (PubMed ID: 23982600)
1. The relationship between lymphocyte subsets and clinico-pathological determinants of survival in patients with primary operable invasive ductal breast cancer.
Mohammed ZM; Going JJ; Edwards J; Elsberger B; McMillan DC
Br J Cancer; 2013 Sep; 109(6):1676-84. PubMed ID: 23982600
[TBL] [Abstract][Full Text] [Related]
2. The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer.
Mohammed ZM; Going JJ; Edwards J; Elsberger B; Doughty JC; McMillan DC
Br J Cancer; 2012 Aug; 107(5):864-73. PubMed ID: 22878371
[TBL] [Abstract][Full Text] [Related]
3. The relationship between the tumour stroma percentage, clinicopathological characteristics and outcome in patients with operable ductal breast cancer.
Gujam FJ; Edwards J; Mohammed ZM; Going JJ; McMillan DC
Br J Cancer; 2014 Jul; 111(1):157-65. PubMed ID: 24874480
[TBL] [Abstract][Full Text] [Related]
4. The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic and macrophage infiltration, microvessel density and survival in patients with primary operable breast cancer.
Murri AM; Hilmy M; Bell J; Wilson C; McNicol AM; Lannigan A; Doughty JC; McMillan DC
Br J Cancer; 2008 Oct; 99(7):1013-9. PubMed ID: 18797461
[TBL] [Abstract][Full Text] [Related]
5. The relationship between tumour budding, the tumour microenvironment and survival in patients with invasive ductal breast cancer.
Gujam FJ; McMillan DC; Mohammed ZM; Edwards J; Going JJ
Br J Cancer; 2015 Sep; 113(7):1066-74. PubMed ID: 26263482
[TBL] [Abstract][Full Text] [Related]
6. The relationship between phosphorylation status of focal adhesion kinases, molecular subtypes, tumour microenvironment and survival in patients with primary operable ductal breast cancer.
Andisha NM; McMillan DC; Gujam FJA; Roseweir A; Edwards J
Cell Signal; 2019 Aug; 60():91-99. PubMed ID: 30981841
[TBL] [Abstract][Full Text] [Related]
7. The relationship between oestrogen receptor-alpha phosphorylation and the tumour microenvironment in patients with primary operable ductal breast cancer.
Cheng KK; Dickson A; Gujam FJ; McMillan DC; Edwards J
Histopathology; 2017 Apr; 70(5):782-797. PubMed ID: 27891654
[TBL] [Abstract][Full Text] [Related]
8. The relationship between members of the canonical NF-κB pathway, components of tumour microenvironment and survival in patients with invasive ductal breast cancer.
Bennett L; Mallon EA; Horgan PG; Paul A; McMillan DC; Edwards J
Oncotarget; 2017 May; 8(20):33002-33013. PubMed ID: 28423692
[TBL] [Abstract][Full Text] [Related]
9. Macrophage infiltrate and prognosis in c-erbB-2-overexpressing breast carcinomas.
Pupa SM; Bufalino R; Invernizzi AM; Andreola S; Rilke F; Lombardi L; Colnaghi MI; Ménard S
J Clin Oncol; 1996 Jan; 14(1):85-94. PubMed ID: 8558226
[TBL] [Abstract][Full Text] [Related]
10. The relationship between total and phosphorylated STAT1 and STAT3 tumour cell expression, components of tumour microenvironment and survival in patients with invasive ductal breast cancer.
Gujam FJ; McMillan DC; Edwards J
Oncotarget; 2016 Nov; 7(47):77607-77621. PubMed ID: 27769057
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical evaluation of immune response in invasive ductal breast cancer of not-otherwise-specified type.
Vgenopoulou S; Lazaris AC; Markopoulos C; Boltetsou E; Kyriakou V; Kavantzas N; Patsouris E; Davaris PS
Breast; 2003 Jun; 12(3):172-8. PubMed ID: 14659323
[TBL] [Abstract][Full Text] [Related]
12. Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes: a meta-analysis.
Gao ZH; Li CX; Liu M; Jiang JY
BMC Cancer; 2020 Nov; 20(1):1150. PubMed ID: 33238978
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
[TBL] [Abstract][Full Text] [Related]
14. The relationship between lymphovascular invasion and angiogenesis, hormone receptors, cell proliferation and survival in patients with primary operable invasive ductal breast cancer.
Mohammed ZM; McMillan DC; Edwards J; Mallon E; Doughty JC; Orange C; Going JJ
BMC Clin Pathol; 2013 Nov; 13(1):31. PubMed ID: 24274633
[TBL] [Abstract][Full Text] [Related]
15. [Preliminary study on lymphocyte subsets of sentinel lymph nodes in breast cancer patients].
Wang S; Fan P; Wu ZY
Zhonghua Zhong Liu Za Zhi; 2004 Apr; 26(4):220-2. PubMed ID: 15312384
[TBL] [Abstract][Full Text] [Related]
16. Thyroid hormone receptor alpha (TRa) tissue expression in ductal invasive breast cancer: A study combining quantitative immunohistochemistry with digital slide image analysis.
Charalampoudis P; Agrogiannis G; Kontzoglou K; Kouraklis G; Sotiropoulos GC
Eur J Surg Oncol; 2017 Aug; 43(8):1428-1432. PubMed ID: 28583788
[TBL] [Abstract][Full Text] [Related]
17. A novel morphologic-molecular recurrence predictive model refines traditional prognostic tools for invasive breast carcinoma.
Ni YB; Tsang JY; Chan SK; Tse GM
Ann Surg Oncol; 2014 Sep; 21(9):2928-33. PubMed ID: 24743910
[TBL] [Abstract][Full Text] [Related]
18. Better predictive value of axillary lymph node (ALN) status after systemic therapy for operable HER2-overexpressing breast cancer: A single-institution retrospective study.
Zhang Y; Mo M; Li JW; Zhou Y; Wu J; Yu KD; Shen ZZ; Shao ZM; Liu GY
Eur J Surg Oncol; 2016 Aug; 42(8):1146-52. PubMed ID: 27365197
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory cells in node-negative breast cancer.
Löfdahl B; Ahlin C; Holmqvist M; Holmberg L; Zhou W; Fjällskog ML; Amini RM
Acta Oncol; 2012 May; 51(5):680-6. PubMed ID: 22268578
[TBL] [Abstract][Full Text] [Related]
20. Automated quantitative analysis of E-cadherin expression in lymph node metastases is predictive of survival in invasive ductal breast cancer.
Harigopal M; Berger AJ; Camp RL; Rimm DL; Kluger HM
Clin Cancer Res; 2005 Jun; 11(11):4083-9. PubMed ID: 15930343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
